Characterization of daptomycin-loaded antibiotic cement

Orthopedics

Volumn 35, Issue 4, 2012, Pages

  Kaplan, Lige ^a   Kurdziel, Michael ^b   Baker, Kevin C ^b   Verner, James ^a  

^a Department of Orthopaedic Surgery ^*  (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; DAPTOMYCIN; POLY(METHYL METHACRYLATE); TOBRAMYCIN;

ARTICLE; BIOMECHANICS; COMPRESSIVE LOADING; COMPRESSIVE MODULUS; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CONCENTRATION; DRUG RELEASE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MATERIALS TESTING; PHYSICAL PARAMETERS; YIELD STRENGTH;

ANTI-BACTERIAL AGENTS; BONE CEMENTS; COMPRESSIVE STRENGTH; DAPTOMYCIN; DIFFUSION; DRUG CARRIERS; ELASTIC MODULUS; HARDNESS; MATERIALS TESTING; POLYMETHYL METHACRYLATE;

EID: 84860701807     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120327-19     Document Type: Article

References (31)

1. Darwiche H, Barsoum WK, Klika A, Krebs VE, Molloy R. Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin Orthop Relat Res. 2010;468(9):2392-2396.
2. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746-1751. (Pubitemid 41061193)
3. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty [published online ahead of print December 19, 2003]. J Antimicrob Chemother. 2004;53(2):329-334. (Pubitemid 38239970)
4. Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I. Twostage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br. 2000;82(5):689-694. (Pubitemid 30497078)
5. Richelsoph KC, Webb ND, Haggard WO. Elution behavior of daptomycin-loaded calcium sulfate pellets: a preliminary study. Clin Orthop Relat Res. 2007;461:68-73.
6. Campoccia D, Montanaro L, Speziale P, Arciola CR. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials. 2010;31(25):6363-6377.
7. Wininger DA, Fass RJ. Antibioticimpregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother. 1996;40(12):2675-2679. (Pubitemid 26404324)
8. Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon [published online ahead of print May 1, 2009]. Clin Orthop Relat Res. 2009;467(7):1732-1739.
9. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med. 2009;360(5):439-443.
10. Critchley IA, Blosser-Middleton RS, Jones ME, Thornsberry C, Sahm DF, Karlowsky JA. Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001. Antimicrob Agents Chemother. 2003;47(5):1689-1693. (Pubitemid 36548555)
11. Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections [published online ahead of print February 10, 2005]. J Antimicrob Chemother. 2005;55(3):283-288. (Pubitemid 40425449)
12. Burns CA. Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy. Scand J Infect Dis. 2006;38(2):133-136. (Pubitemid 43203242)
13. Dretler R, Branch T. MRSA knee infection treated successfully with daptomycin after two failed prolonged high-dose courses of vancomycin. Infect Dis Clin Pract. 2005;13(6):327-329. (Pubitemid 41689690)
14. Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence [published online ahead of print April 24, 2007]. Int J Antimicrob Agents. 2007;30(3):202-209. (Pubitemid 47126811)
15. Hall EW, Rouse MS, Jacofsky DJ, et al. Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber. Diagn Microbiol Infect Dis. 2004;50(4):261-265. (Pubitemid 39593149)
16. Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am. 2009;91(10):2480-2490.
17. Patel A, Calfee RP, Plante M, Fischer SA, Arcand N, Born C. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. J Bone Joint Surg Br. 2008;90(11):1401-1406.
18. Rao N, Regalla DM. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop Relat Res. 2006;451:34-37. (Pubitemid 44511305)
19. Rice DA, Mendez-Vigo L. Daptomycin in bone and joint infections: a review of the literature [published online ahead of print November 7, 2008]. Arch Orthop Trauma Surg. 2009;129(11):1495-1504.
20. Webb ND, McCanless JD, Courtney HS, Bumgardner JD, Haggard WO. Daptomycin eluted from calcium sulfate appears effective against Staphylococcus [published online ahead of print April 23, 2008]. Clin Orthop Relat Res. 2008;466(6):1383-1387.
21. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79-85. (Pubitemid 39362835)
22. Meek RM, Masri BA, Dunlop D, et al. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85(10):1888-1892. (Pubitemid 37259722)
23. Anagnostakos K, Kelm J. Enhancement of antibiotic elution from acrylic bone cement. J Biomed Mater Res B Appl Biomater. 2009;90(1):467-475.
24. Pelletier MH, Malisano L, Smitham PJ, Okamoto K, Walsh WR. The compressive properties of bone cements containing large doses of antibiotics [published online ahead of print April 3, 2008]. J Arthroplasty. 2009;24(3):454-460.
25. Brock HS, Moodie PG, Hendricks KJ, McIff TE. Compression strength and porosity of single-antibiotic cement vacuum-mixed with vancomycin [published online ahead of print August 12, 2009]. J Arthroplasty. 2010;25(6):990-997.
26. Liacouras PC, Owen JR, Jiranek WA, Wayne JS. Effect of pigmentation on the mechanical and polymerization characteristics of bone cement. J Arthroplasty. 2006;21(4):606-611. (Pubitemid 43866396)
27. van de Belt H, Neut D, Uges DR, et al. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials. 2000;21(19):1981-1987. (Pubitemid 30433826)
28. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res. 1991; (264): 302-308.
29. Klekamp J, Dawson JM, Haas DW, De Boer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty. 1999;14(3):339-346. (Pubitemid 29172251)
30. ASTM Standard F451, "Standard Specification for Acrylic Bone Cement." West Conshocken, PA: ASTM International; 2008. DOI: 10.1520/F0451-08
31. Sader HS, Fritsche TR, Jones RN. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003) [published online ahead of print November 2, 2005]. Diagn Microbiol Infect Dis. 2005;53(4):329-332. (Pubitemid 41796907)